---
// src/pages/science/gangliosides.astro
import BaseLayout from "../../layouts/BaseLayout.astro";
import { useTranslations } from "../../i18n";
import GangliosideMap from "../../components/science/GangliosideMap";

const t = useTranslations('en');
---

<BaseLayout 
  title="The Ganglioside Operating System"
  description="Understanding gangliosides as a fundamental communication infrastructure in the nervous system ‚Äî electrostatic signaling, vesicle clocks, and receptor selectivity."
>
  <!-- Page Header -->
  <section class="bg-gradient-to-b from-slate-900 to-slate-800 text-white py-16">
    <div class="max-w-7xl mx-auto px-4 sm:px-6 lg:px-8">
      <nav class="text-sm text-slate-400 mb-4">
        <a href="/" class="hover:text-white transition-colors">Home</a>
        <span class="mx-2">/</span>
        <a href="/science/" class="hover:text-white transition-colors">Science</a>
        <span class="mx-2">/</span>
        <span class="text-white">Gangliosides</span>
      </nav>
      <h1 class="text-4xl md:text-5xl font-bold mb-4">The Ganglioside Operating System</h1>
      <p class="text-xl text-slate-300 max-w-3xl">
        Beyond receptors and storage diseases: understanding gangliosides as a fundamental 
        <strong>communication infrastructure</strong> that enables neurons to send, receive, 
        and selectively filter signals across time and distance.
      </p>
    </div>
  </section>

  <!-- NEW: Paradigm Shift Introduction -->
  <section class="py-8 bg-amber-50 border-b border-amber-200">
    <div class="max-w-4xl mx-auto px-4 sm:px-6 lg:px-8">
      <div class="key-concept">
        <div class="key-concept-title">üîÑ A New Perspective on Gangliosides</div>
        <p class="mb-3">
          Traditional ganglioside research focuses on <em>pathology</em>: "GT1b is a receptor for tetanus toxin," 
          "GM2 accumulation causes Tay-Sachs." But this begs the question: <strong>Why do neurons invest so 
          heavily in this complex system?</strong>
        </p>
        <p class="mb-0">
          This page explores the <strong>physiological function</strong> of gangliosides ‚Äî proposing that they 
          form an "operating system" for neuronal communication, with electrostatic properties that enable 
          sophisticated filtering of signals by time, distance, and source.
        </p>
      </div>
    </div>
  </section>

  <!-- Introduction -->
  <section class="py-12">
    <div class="max-w-4xl mx-auto px-4 sm:px-6 lg:px-8">
      <div class="prose-science">
        <h2>What are Gangliosides?</h2>
        <p>
          Gangliosides are complex sphingolipids containing one or more sialic acid residues. 
          They are abundant in the nervous system, comprising <strong>10-12% of total lipid content</strong> in 
          neuronal membranes ‚Äî an enormous metabolic investment that hints at fundamental importance.
        </p>
        
        <div class="info-box">
          <h4 class="font-bold text-blue-800 mb-2">üí° The Central Question</h4>
          <p class="text-blue-700 text-sm mb-0">
            Each sialic acid residue carries a <strong>negative charge</strong>. Why would neurons coat 
            themselves and their vesicles with densely charged molecules? The answer, we propose, lies 
            in <strong>electrostatic signaling</strong> ‚Äî using charge as a communication medium.
          </p>
        </div>
        
        <div class="key-concept">
          <div class="key-concept-title">Key Concept: GT1b Ganglioside</div>
          <p class="mb-0">
            GT1b is a trisialoganglioside with <strong>three sialic acids</strong> ‚Äî giving it a strong 
            negative charge. It serves as the primary receptor for tetanus toxin and enables 
            retrograde axonal transport. We propose GT1b is part of a larger <strong>neurotrophin 
            transport highway</strong>.
          </p>
        </div>
        
        <h2>The Svennerholm Classification</h2>
        <p>
          Gangliosides are classified using the Svennerholm nomenclature system, where:
        </p>
        <ul>
          <li><strong>G</strong> = Ganglioside</li>
          <li><strong>M, D, T, Q</strong> = Number of sialic acid residues (Mono, Di, Tri, Quadra)</li>
          <li><strong>1, 2, 3</strong> = Order of migration on chromatography</li>
          <li><strong>a, b, c</strong> = Position of sialic acids on the sugar chain</li>
        </ul>

        <h2>A-Series vs B-Series: Critical Differences</h2>
        <p>
          The distinction between a-series (monosialo) and b-series (disialo) gangliosides is 
          <strong>central to understanding the hypothesis</strong>. These series differ fundamentally 
          in their behavior, localization, and clinical significance.
        </p>

        <table class="w-full text-sm my-6">
          <thead>
            <tr class="border-b bg-slate-50">
              <th class="text-left py-2 px-2">Property</th>
              <th class="text-left py-2 px-2">A-Series (Monosialo)</th>
              <th class="text-left py-2 px-2">B-Series (Disialo)</th>
            </tr>
          </thead>
          <tbody>
            <tr class="border-b">
              <td class="py-2 px-2 font-medium">Examples</td>
              <td class="py-2 px-2">GM3 ‚Üí GM2 ‚Üí GM1 ‚Üí GD1a</td>
              <td class="py-2 px-2">GD3 ‚Üí GD2 ‚Üí GD1b ‚Üí GT1b ‚Üí GQ1b</td>
            </tr>
            <tr class="border-b">
              <td class="py-2 px-2 font-medium">Key enzyme</td>
              <td class="py-2 px-2">ST3GAL5 (GM3 synthase)</td>
              <td class="py-2 px-2">ST8SIA1 (GD3 synthase)</td>
            </tr>
            <tr class="border-b">
              <td class="py-2 px-2 font-medium">Membrane behavior</td>
              <td class="py-2 px-2">Stable in lipid rafts</td>
              <td class="py-2 px-2">Dynamic, prone to export</td>
            </tr>
            <tr class="border-b">
              <td class="py-2 px-2 font-medium">Primary location</td>
              <td class="py-2 px-2">Nodes of Ranvier, myelin</td>
              <td class="py-2 px-2">Synaptic terminals, oculomotor nerves</td>
            </tr>
            <tr class="border-b">
              <td class="py-2 px-2 font-medium">Shedding rate</td>
              <td class="py-2 px-2 text-green-600">Low</td>
              <td class="py-2 px-2 text-amber-600 font-bold">High</td>
            </tr>
            <tr class="border-b">
              <td class="py-2 px-2 font-medium">Storage diseases</td>
              <td class="py-2 px-2">GM1/GM2 gangliosidosis</td>
              <td class="py-2 px-2 text-amber-600 font-bold">None known!</td>
            </tr>
            <tr class="border-b bg-red-50">
              <td class="py-2 px-2 font-medium">Immune exposure</td>
              <td class="py-2 px-2">Lower</td>
              <td class="py-2 px-2 text-red-600 font-bold">Higher (Miller Fisher, GBS)</td>
            </tr>
          </tbody>
        </table>

        <div class="key-concept">
          <div class="key-concept-title">The Shedding Mechanism</div>
          <p>
            B-series gangliosides (GD3, GT1b, GQ1b) have a <strong>higher negative charge</strong> 
            due to their two sialic acid residues. This promotes export via extracellular vesicles 
            (EVs/exosomes) through ceramide-dependent budding. This "bypass" of lysosomal 
            degradation has two critical consequences:
          </p>
          <ol class="mt-2 mb-0">
            <li><strong>No lysosomal accumulation</strong> ‚Üí No storage disease phenotype</li>
            <li><strong>Increased extracellular exposure</strong> ‚Üí Higher vulnerability to autoimmune attack</li>
          </ol>
        </div>

        <!-- Key Illustration: A-series vs B-series -->
        <figure class="my-8">
          <img 
            src="/images/intracellular-storage-extracellular-shedding.png" 
            alt="A-series (GM1) leads to intracellular storage in lysosomes, while B-series (GT1b) is exported via exosomes for extracellular communication"
            class="w-full rounded-lg border border-slate-200 shadow-lg"
          />
          <figcaption class="text-sm text-slate-600 mt-3 text-center">
            <strong>The Great Divide:</strong> A-series gangliosides (GM1) are directed to lysosomes 
            for degradation ‚Äî a "dead end" that causes storage diseases when blocked. B-series 
            gangliosides (GT1b) are exported via exosomes for intercellular communication ‚Äî 
            bypassing lysosomal accumulation but increasing immune exposure.
          </figcaption>
        </figure>

        <h3>Clinical Evidence: Miller Fisher Syndrome</h3>
        <p>
          Miller Fisher syndrome (MFS) perfectly illustrates the b-series vulnerability. This 
          variant of Guillain-Barr√© syndrome is characterized by:
        </p>
        <ul>
          <li><strong>Clinical triad:</strong> Ophthalmoplegia, ataxia, areflexia</li>
          <li><strong>Anti-GQ1b antibodies:</strong> Present in 85-90% of cases</li>
          <li><strong>Post-infectious trigger:</strong> Often <em>Campylobacter jejuni</em></li>
          <li><strong>Molecular mimicry:</strong> Bacterial lipo-oligosaccharides resemble GQ1b epitopes</li>
        </ul>

        <div class="warning-box">
          <h4 class="font-bold text-amber-800 mb-2">Why Oculomotor Nerves?</h4>
          <p class="text-amber-700 text-sm mb-0">
            The oculomotor nerves and dorsal root ganglia are <strong>enriched in b-series gangliosides</strong> 
            (GT1b, GQ1b). Their high shedding rate increases local immune exposure, explaining the 
            selective vulnerability in MFS. The same mechanism may apply to orexin neurons in 
            post-Pandemrix narcolepsy.
          </p>
        </div>

        <div class="info-box mt-6">
          <h4 class="font-bold text-blue-800 mb-2">A-Series (GM3) and the Auditory System</h4>
          <p class="text-blue-700 text-sm mb-2">
            GM3 is essential for cochlear function ‚Äî GM3 synthase deficiency causes profound deafness. 
            We explored whether H3N2 influenza (which binds GM3) could explain "Havana Syndrome" via 
            similar ganglioside-mediated mechanisms.
          </p>
          <p class="text-slate-600 text-sm mb-0">
            <strong class="text-red-600">Result:</strong> After critical evaluation, this hypothesis was found 
            <strong>unlikely</strong>. See: <a href="/speculation/havana-syndrome/" class="text-red-600 underline">The Havana Hypothesis (Falsified)</a>
          </p>
        </div>

        <!-- NEW: Ganglioside Degradation Section -->
        <h2 class="mt-12">Ganglioside Degradation: The Four Mammalian Neuraminidases</h2>
        <p>
          Understanding ganglioside <strong>degradation</strong> is just as important as understanding biosynthesis. 
          Four mammalian neuraminidases (NEU1‚ÄìNEU4) are responsible for removing sialic acids from gangliosides 
          and glycoproteins ‚Äî but they differ dramatically in their <strong>substrate specificity</strong>, 
          <strong>subcellular localization</strong>, and <strong>physiological roles</strong>.
        </p>

        <div class="key-concept">
          <div class="key-concept-title">Why Does This Matter?</div>
          <p class="mb-0">
            Understanding which neuraminidase acts on which ganglioside is critical for the narcolepsy hypothesis. 
            For example, <strong>NEU1</strong> (often discussed in genetic studies) has <strong>minimal activity 
            against gangliosides like GT1b</strong> ‚Äî it primarily acts on N-glycans. If ganglioside accumulation 
            is relevant to NT1, we must look at <strong>NEU3 or NEU4</strong> instead.
          </p>
        </div>

        <h3>The Four Neuraminidases: A Comparison</h3>
        <table class="w-full text-sm my-6">
          <thead>
            <tr class="border-b bg-slate-50">
              <th class="text-left py-2 px-2">Enzyme</th>
              <th class="text-left py-2 px-2">Location</th>
              <th class="text-left py-2 px-2">Primary Substrates</th>
              <th class="text-left py-2 px-2">Ganglioside Activity</th>
            </tr>
          </thead>
          <tbody>
            <tr class="border-b bg-cyan-50">
              <td class="py-2 px-2 font-bold text-cyan-800">NEU1</td>
              <td class="py-2 px-2">Lysosomal</td>
              <td class="py-2 px-2">Oligosaccharides, N-glycans (glycoproteins)</td>
              <td class="py-2 px-2 text-red-600 font-bold">Very low / minimal</td>
            </tr>
            <tr class="border-b">
              <td class="py-2 px-2 font-bold text-slate-700">NEU2</td>
              <td class="py-2 px-2">Cytosolic</td>
              <td class="py-2 px-2">Broad (in vitro), unclear physiologically</td>
              <td class="py-2 px-2 text-amber-600">Moderate (but cytosolic location limits access)</td>
            </tr>
            <tr class="border-b bg-green-50">
              <td class="py-2 px-2 font-bold text-green-800">NEU3</td>
              <td class="py-2 px-2">Plasma membrane</td>
              <td class="py-2 px-2">Gangliosides (GM3 ‚Üí lactosylceramide, etc.)</td>
              <td class="py-2 px-2 text-green-600 font-bold">Highest specificity!</td>
            </tr>
            <tr class="border-b bg-purple-50">
              <td class="py-2 px-2 font-bold text-purple-800">NEU4</td>
              <td class="py-2 px-2">Lysosomal / Mitochondrial / ER</td>
              <td class="py-2 px-2">Gangliosides, glycoproteins, oligosaccharides (broad)</td>
              <td class="py-2 px-2 text-purple-600 font-bold">High (broad specificity)</td>
            </tr>
          </tbody>
        </table>

        <div class="grid md:grid-cols-2 gap-6 my-6">
          <div class="bg-cyan-50 border border-cyan-200 rounded-lg p-4">
            <h4 class="font-bold text-cyan-800 mb-2">NEU1 ‚Äî The "Glycoprotein Sialidase"</h4>
            <ul class="text-cyan-700 text-sm space-y-1">
              <li>‚Ä¢ <strong>Location:</strong> Lysosome (forms complex with Cathepsin A and Œ≤-galactosidase)</li>
              <li>‚Ä¢ <strong>Substrates:</strong> Œ±2,3- and Œ±2,6-linked sialic acids on oligosaccharides and glycoproteins</li>
              <li>‚Ä¢ <strong>Gangliosides:</strong> <span class="text-red-600 font-bold">Minimal activity</span> ‚Äî does NOT efficiently hydrolyze gangliosides</li>
              <li>‚Ä¢ <strong>Deficiency:</strong> Causes Sialidosis (accumulation of sialylated oligosaccharides, NOT gangliosides)</li>
            </ul>
            <p class="text-cyan-600 text-xs mt-2 italic">
              ‚ö†Ô∏è NEU1 is often mentioned in narcolepsy genetics due to its MHC location, but it does NOT act on GT1b.
            </p>
          </div>

          <div class="bg-green-50 border border-green-200 rounded-lg p-4">
            <h4 class="font-bold text-green-800 mb-2">NEU3 ‚Äî The "Ganglioside Specialist"</h4>
            <ul class="text-green-700 text-sm space-y-1">
              <li>‚Ä¢ <strong>Location:</strong> Plasma membrane (cell surface and inner leaflet)</li>
              <li>‚Ä¢ <strong>Substrates:</strong> Gangliosides ‚Äî requires hydrophobic aglycon</li>
              <li>‚Ä¢ <strong>Key reaction:</strong> GM3 ‚Üí lactosylceramide (and similar)</li>
              <li>‚Ä¢ <strong>Role:</strong> Primary enzyme for ganglioside desialylation at cell surface</li>
            </ul>
            <p class="text-green-600 text-xs mt-2 italic">
              ‚úì If ganglioside accumulation is relevant to NT1, NEU3 (Chr 11q13) is a better candidate than NEU1.
            </p>
          </div>
        </div>

        <div class="grid md:grid-cols-2 gap-6 my-6">
          <div class="bg-slate-50 border border-slate-200 rounded-lg p-4">
            <h4 class="font-bold text-slate-800 mb-2">NEU2 ‚Äî The "Cytosolic Enigma"</h4>
            <ul class="text-slate-700 text-sm space-y-1">
              <li>‚Ä¢ <strong>Location:</strong> Cytosol (no membrane association)</li>
              <li>‚Ä¢ <strong>In vitro:</strong> Broad specificity including some gangliosides</li>
              <li>‚Ä¢ <strong>In vivo:</strong> Physiological role unclear ‚Äî cytosolic location limits access to membrane lipids</li>
              <li>‚Ä¢ <strong>Note:</strong> Some species (fish) lack NEU2 ortholog entirely</li>
            </ul>
          </div>

          <div class="bg-purple-50 border border-purple-200 rounded-lg p-4">
            <h4 class="font-bold text-purple-800 mb-2">NEU4 ‚Äî The "Lysosomal Backup"</h4>
            <ul class="text-purple-700 text-sm space-y-1">
              <li>‚Ä¢ <strong>Location:</strong> Lysosomal lumen, mitochondria, ER</li>
              <li>‚Ä¢ <strong>Substrates:</strong> Broad ‚Äî gangliosides (GD1a, GM1, GM2), glycoproteins, oligosaccharides</li>
              <li>‚Ä¢ <strong>Role:</strong> Contributes to lysosomal ganglioside catabolism</li>
              <li>‚Ä¢ <strong>Key finding:</strong> NEU4 overexpression rescues sialidosis cells (complements NEU1 deficiency)</li>
            </ul>
          </div>
        </div>

        <div class="warning-box">
          <h4 class="font-bold text-amber-800 mb-2">‚ö†Ô∏è Critical Point for Narcolepsy Hypothesis</h4>
          <p class="text-amber-700 text-sm mb-2">
            <strong>NEU1</strong> lies in the MHC region (6p21.33) near HLA-DQB1*06:02 and is often discussed 
            as a candidate gene. However, NEU1 has <strong>minimal activity against gangliosides like GT1b</strong>.
          </p>
          <p class="text-amber-700 text-sm mb-0">
            If ganglioside metabolism is relevant to narcolepsy pathogenesis, the relevant enzymes would be 
            <strong>NEU3</strong> (11q13.5) or <strong>NEU4</strong> (2q37.3) ‚Äî which are NOT in linkage disequilibrium 
            with the HLA risk haplotype. This is an important distinction.
          </p>
        </div>

        <h3>The Extracellular "Vesicle Clock"</h3>
        <p>
          One fascinating aspect of ganglioside biology is that neuraminidases also exist in the 
          <strong>extracellular space</strong>. These extracellular sialidases progressively strip sialic 
          acids from vesicles as they travel through the nervous system, creating a "biological clock" that 
          encodes time and distance.
        </p>

        <div class="info-box">
          <h4 class="font-bold text-blue-800 mb-2">The "Vesicle Clock" Concept</h4>
          <p class="text-blue-700 text-sm mb-0">
            As a GT1b-rich vesicle travels, extracellular neuraminidases progressively convert it: 
            GT1b ‚Üí GD1b ‚Üí GM1 ‚Üí asialo-GM1. This gradual "stripping" creates a time/distance signature 
            that receiving neurons can read ‚Äî enabling sophisticated filtering of signals by source and age.
          </p>
        </div>

        <!-- References for this section -->
        <div class="bg-slate-100 rounded-lg p-4 my-6">
          <h4 class="font-bold text-slate-800 mb-2 text-sm">References: Neuraminidase Specificity</h4>
          <ol class="text-slate-600 text-xs space-y-1">
            <li>1. Miyagi T, Yamaguchi K (2012). Mammalian sialidases: physiological and pathological roles in cellular functions. 
              <em>Glycobiology</em>. 22(7):880-896. 
              <a href="https://doi.org/10.1093/glycob/cws076" class="text-blue-600 hover:underline" target="_blank">doi:10.1093/glycob/cws076</a></li>
            <li>2. Aliev NA et al. (2014). Structural Basis for Substrate Specificity of Mammalian Neuraminidases. 
              <em>PLoS ONE</em>. 9(9):e106320. 
              <a href="https://doi.org/10.1371/journal.pone.0106320" class="text-blue-600 hover:underline" target="_blank">doi:10.1371/journal.pone.0106320</a></li>
            <li>3. Illes K et al. (2023). Structure of the immunoregulatory sialidase NEU1. 
              <em>Science Advances</em>. 9(22):eadf8169. 
              <a href="https://doi.org/10.1126/sciadv.adf8169" class="text-blue-600 hover:underline" target="_blank">doi:10.1126/sciadv.adf8169</a></li>
            <li>4. Seyrantepe V et al. (2004). Neu4, a novel human lysosomal lumen sialidase, confers normal phenotype to sialidosis and galactosialidosis cells. 
              <em>J Biol Chem</em>. 279(35):37021-9. 
              <a href="https://doi.org/10.1074/jbc.M403079200" class="text-blue-600 hover:underline" target="_blank">doi:10.1074/jbc.M403079200</a></li>
          </ol>
        </div>
      </div>
    </div>
  </section>

  <!-- Interactive Diagram -->
  <section class="py-12 bg-slate-100">
    <div class="max-w-7xl mx-auto px-4 sm:px-6 lg:px-8">
      <GangliosideMap 
        client:load
        labels={{
          title: t.sections.gangliosides.title,
          subtitle: t.sections.gangliosides.subtitle,
          biosynthesis: t.sections.gangliosides.biosynthesis,
          degradation: t.sections.gangliosides.degradation,
          clinicalRelevance: t.sections.gangliosides.clinical_relevance,
        }}
      />
    </div>
  </section>

  <!-- Detailed Explanation: RESTRUCTURED FOR BETTER FLOW -->
  <section class="py-12">
    <div class="max-w-4xl mx-auto px-4 sm:px-6 lg:px-8">
      <div class="prose-science">
        
        <!-- PART 1: THE GT1B TRANSPORT SYSTEM -->
        <h2>Why B-Series Gangliosides Are Special</h2>
        <p>
          The distinction between A-series and B-series gangliosides isn't just biochemistry ‚Äî 
          it's the key to understanding how substances travel through the nervous system. 
          Let's build this understanding step by step.
        </p>

        <h3>Step 1: The GT1b Paradox ‚Äî No Storage Disease</h3>
        <p>
          Here's a puzzle: most gangliosides cause devastating storage diseases when they accumulate 
          (GM1 gangliosidosis, Tay-Sachs for GM2). Yet <strong>there is no known disease caused by 
          GT1b or GD1b accumulation</strong>. Why?
        </p>
        
        <p>
          The answer reveals something fundamental: <strong>B-series gangliosides are exported, 
          not stored</strong>. When GT1b levels rise, the excess is released via extracellular 
          vesicles (exosomes) ‚Äî a "bypass" of normal lysosomal degradation.
        </p>

        <!-- Key Illustration: Cholera vs Tetanus Transport -->
        <figure class="my-8">
          <img 
            src="/images/choleratoxin-tetanus-toxin-transport.jpg" 
            alt="Cholera toxin (GM1) stays intracellular targeting Golgi, while Tetanus toxin (GT1b) is released via signaling endosomes for trans-synaptic jump"
            class="w-full rounded-lg border border-slate-200 shadow-lg"
          />
          <figcaption class="text-sm text-slate-600 mt-3 text-center">
            <strong>Two Toxins, Two Fates:</strong> Cholera toxin (binding GM1) remains intracellular. 
            Tetanus toxin (binding GT1b) is released and makes a <em>trans-synaptic jump</em>. 
            This is why GT1b-bound substances spread through neural circuits.
          </figcaption>
        </figure>

        <h3>Step 2: The Electrostatic Explanation</h3>
        <p>
          Why does B-series get exported while A-series gets stored? The answer lies in 
          <strong>electrical charge</strong>.
        </p>

        <!-- Electrostatic Transport Illustration -->
        <figure class="my-8">
          <img 
            src="/images/electrostatic-vesicle-transport.svg" 
            alt="Electrostatic vesicle transport showing how negative charges on GT1b-rich vesicles enable 'gliding' through the nervous system while specific receptors enable targeted delivery"
            class="w-full rounded-lg border border-slate-200 shadow-lg bg-white"
          />
          <figcaption class="text-sm text-slate-600 mt-3 text-center">
            <strong>The "Slippery Soap" Mechanism:</strong> Both vesicles and cell surfaces are negatively charged. 
            This repulsion prevents random adhesion ‚Äî the vesicle "glides" through the extracellular space. 
            Delivery occurs only when specific receptor binding overcomes the electrostatic barrier.
          </figcaption>
        </figure>

        <div class="bg-blue-50 border border-blue-200 rounded-lg p-6 my-6">
          <h4 class="font-bold text-blue-800 mb-4">‚ö° The Physics of Ganglioside Transport</h4>
          
          <div class="grid md:grid-cols-2 gap-4 mb-4">
            <div class="bg-white rounded p-4 border border-blue-200">
              <h5 class="font-bold text-blue-700 mb-2">Sialic Acid = Negative Charge</h5>
              <p class="text-slate-700 text-sm mb-2">
                Each sialic acid residue carries a <strong>negative charge</strong> at physiological pH.
              </p>
              <ul class="text-slate-600 text-sm space-y-1 ml-4 list-disc">
                <li>GM1 (A-series): 1 sialic acid ‚Üí <span class="text-slate-500">low charge</span></li>
                <li>GT1b (B-series): 3 sialic acids ‚Üí <span class="text-blue-600 font-bold">high charge</span></li>
                <li>GQ1b (B-series): 4 sialic acids ‚Üí <span class="text-blue-700 font-bold">very high charge</span></li>
              </ul>
            </div>
            
            <div class="bg-white rounded p-4 border border-blue-200">
              <h5 class="font-bold text-blue-700 mb-2">Zeta-Potential & Vesicle Stability</h5>
              <p class="text-slate-700 text-sm mb-2">
                High negative charge creates "Zeta-potential" ‚Äî a surface charge that:
              </p>
              <ul class="text-slate-600 text-sm space-y-1 ml-4 list-disc">
                <li>Prevents vesicle aggregation</li>
                <li>Promotes membrane curvature and budding</li>
                <li>Enables smooth diffusion through the extracellular matrix</li>
              </ul>
            </div>
          </div>

          <div class="bg-blue-100 rounded p-4">
            <p class="text-blue-800 text-sm mb-0">
              <strong>Key insight:</strong> The polysialylation of B-series gangliosides isn't just 
              chemistry ‚Äî it's an <em>electrostatic motor</em> that drives vesicle export. 
              A-series (low charge) stays put; B-series (high charge) gets shipped out.
            </p>
          </div>
        </div>

        <h3>Step 3: What Does GT1b Transport?</h3>
        <p>
          If B-series gangliosides are "designed" for export and intercellular communication, 
          what do they normally carry? This is where it gets interesting.
        </p>

        <div class="bg-amber-50 border-l-4 border-amber-400 p-3 my-4 text-sm">
          <strong class="text-amber-800">‚ö†Ô∏è Note:</strong> 
          <span class="text-amber-700">The following "Neurotrophin Highway" concept is a <em>hypothesis</em> 
          that builds on established GT1b biology but extends it speculatively.</span>
        </div>

        <div class="bg-emerald-50 border border-emerald-200 rounded-lg p-6 my-6">
          <h4 class="font-bold text-emerald-800 mb-4">üöÇ The Neurotrophin Cargo</h4>
          <p class="text-emerald-700 text-sm mb-4">
            <strong>Established facts:</strong> Key growth factors depend on GT1b for their signaling:
          </p>
          
          <div class="grid md:grid-cols-3 gap-3 mb-4">
            <div class="bg-white rounded p-3 border border-emerald-200">
              <h5 class="font-bold text-emerald-700 text-sm mb-1">BDNF</h5>
              <p class="text-slate-600 text-xs">
                Brain-derived neurotrophic factor. GT1b required for TrkB receptor dimerization. 
                Can be shed in exosomes <em>together with gangliosides</em>.
              </p>
            </div>
            <div class="bg-white rounded p-3 border border-emerald-200">
              <h5 class="font-bold text-emerald-700 text-sm mb-1">GDNF</h5>
              <p class="text-slate-600 text-xs">
                Glial cell line-derived neurotrophic factor. Critical for dopaminergic neuron survival. 
                Requires GT1b-rich lipid rafts.
              </p>
            </div>
            <div class="bg-white rounded p-3 border border-emerald-200">
              <h5 class="font-bold text-emerald-700 text-sm mb-1">MAG</h5>
              <p class="text-slate-600 text-xs">
                Myelin-associated glycoprotein. Binds GT1b on axon surfaces ‚Äî <strong>proof that 
                GT1b is exposed extracellularly</strong>.
              </p>
            </div>
          </div>

          <div class="bg-emerald-100 rounded p-4">
            <h5 class="font-bold text-emerald-800 mb-2">üîë Signaling Endosomes</h5>
            <p class="text-emerald-700 text-sm mb-2">
              When neurons receive growth factors, the receptor complex is internalized into 
              <strong>"signaling endosomes"</strong> that travel retrogradely to the nucleus 
              with the message "Survive!".
            </p>
            <p class="text-emerald-800 text-sm font-semibold mb-0">
              GT1b is a critical membrane component of these endosomes. 
              <strong>Anything that binds GT1b gains access to this survival signal highway.</strong>
            </p>
          </div>
        </div>

        <h3>Step 4: The Complete Delivery System</h3>
        <p>
          Here's what makes GT1b-rich vesicles remarkable: they don't just <em>carry</em> cargo ‚Äî 
          they deliver a <strong>complete signaling package</strong>.
        </p>

        <div class="bg-gradient-to-r from-emerald-50 to-blue-50 rounded-lg p-6 my-6 border border-emerald-200">
          <h4 class="font-bold text-emerald-800 mb-4">üéÅ The "Complete Signal Kit"</h4>
          
          <div class="grid md:grid-cols-2 gap-4 mb-4">
            <div>
              <h5 class="font-bold text-slate-700 mb-2">What a free protein does:</h5>
              <ul class="text-slate-600 text-sm space-y-1 ml-4 list-disc">
                <li>Diffuses randomly</li>
                <li>Gets captured by extracellular matrix</li>
                <li>Degraded by proteases</li>
                <li>Hopes to find an active receptor</li>
              </ul>
            </div>
            <div>
              <h5 class="font-bold text-emerald-700 mb-2">What a GT1b-rich vesicle does:</h5>
              <ul class="text-emerald-600 text-sm space-y-1 ml-4 list-disc">
                <li>Travels electrostatically stabilized</li>
                <li>Shields cargo from proteases</li>
                <li>Delivers both ligand AND receptor cofactor</li>
                <li>Provides a pre-assembled signaling platform</li>
              </ul>
            </div>
          </div>

          <p class="text-slate-700 text-sm mb-0 bg-white rounded p-3">
            <strong>The key:</strong> TrkB receptors need lipid rafts with GT1b to signal efficiently. 
            A GT1b-rich vesicle carrying BDNF delivers <em>both</em> ‚Äî the growth factor and the 
            membrane environment needed to respond to it.
          </p>
        </div>

        <!-- Illustration -->
        <figure class="my-8">
          <img 
            src="/images/Retrogra-feedback-signal.png" 
            alt="Retrograde feedback signal via GT1b at sensory nerve ending"
            class="w-full rounded-lg border border-slate-200 shadow-lg"
          />
          <figcaption class="text-sm text-slate-600 mt-3 text-center">
            At a sensory nerve ending, GT1b mediates the "handshake" with target tissue. 
            Signaling endosomes capture trophic signals and transport them retrogradely. 
            <strong>This pathway can be hijacked by pathogens or vaccine antigens with GT1b affinity.</strong>
          </figcaption>
        </figure>

        <!-- NEW: VESICLE CLOCK HYPOTHESIS -->
        <h3>Step 5: The Vesicle Clock ‚Äî Time and Distance Encoding</h3>
        
        <div class="bg-amber-50 border-l-4 border-amber-400 p-4 mb-4">
          <p class="text-amber-800 text-sm font-medium mb-0">
            ‚ö†Ô∏è <strong>Novel Hypothesis:</strong> The following concept extends known ganglioside biology 
            into a proposed functional framework. It represents original thinking, not established science.
          </p>
        </div>

        <p>
          Here's a remarkable implication of the electrostatic model: <strong>vesicles carry a built-in clock</strong>.
        </p>

        <!-- Vesicle Clock Illustration -->
        <figure class="my-8">
          <img 
            src="/images/vesicle-clock-diagram.svg" 
            alt="Vesicle Clock: showing how neuraminidase progressively strips sialic acids, creating a biological timer that encodes time and distance traveled"
            class="w-full rounded-lg border border-slate-200 shadow-lg bg-white"
          />
          <figcaption class="text-sm text-slate-600 mt-3 text-center">
            <strong>The Vesicle Clock:</strong> Neuraminidase in the extracellular space progressively cleaves 
            sialic acids. A vesicle's charge level encodes how long (and how far) it has traveled.
          </figcaption>
        </figure>

        <div class="bg-purple-50 border border-purple-200 rounded-lg p-6 my-6">
          <h4 class="font-bold text-purple-800 mb-4">‚è±Ô∏è How the Vesicle Clock Works</h4>
          
          <div class="space-y-4">
            <div class="bg-white rounded p-4 border border-purple-200">
              <h5 class="font-bold text-purple-700 mb-2">1. Initial State: Fully Charged</h5>
              <p class="text-slate-700 text-sm mb-0">
                When a vesicle is released, it's coated with GT1b (3 sialic acids) or GQ1b (4 sialic acids). 
                <strong>Maximum negative charge = "fresh" vesicle.</strong>
              </p>
            </div>
            
            <div class="bg-white rounded p-4 border border-purple-200">
              <h5 class="font-bold text-purple-700 mb-2">2. Transit: Progressive Cleavage</h5>
              <p class="text-slate-700 text-sm mb-0">
                Extracellular neuraminidases (sialidases) clip sialic acids one by one: 
                GT1b ‚Üí GD1b ‚Üí GM1 ‚Üí LacCer. <strong>Charge decreases over time.</strong>
              </p>
            </div>
            
            <div class="bg-white rounded p-4 border border-purple-200">
              <h5 class="font-bold text-purple-700 mb-2">3. Result: Charge = Age/Distance</h5>
              <p class="text-slate-700 text-sm mb-0">
                A highly charged vesicle is "young" (traveled a short distance). 
                A weakly charged vesicle is "old" (traveled far). <strong>The charge IS the timestamp.</strong>
              </p>
            </div>
          </div>
        </div>

        <h3>Step 6: Receptor Selectivity ‚Äî Tuning the Filter</h3>
        <p>
          If vesicle charge encodes time/distance, then <strong>receptors can selectively filter signals</strong> 
          by adjusting their own ganglioside content.
        </p>

        <!-- Receptor Selectivity Illustration -->
        <figure class="my-8">
          <img 
            src="/images/receptor-selectivity-tuning.svg" 
            alt="Receptor selectivity: showing how receptors with different GT1b levels accept different vesicle populations"
            class="w-full rounded-lg border border-slate-200 shadow-lg bg-white"
          />
          <figcaption class="text-sm text-slate-600 mt-3 text-center">
            <strong>Receptor Selectivity:</strong> By adjusting its ganglioside content, a receptor can 
            dynamically filter which vesicles it accepts ‚Äî either "fresh" (short-distance) or "old" (long-distance).
          </figcaption>
        </figure>

        <div class="bg-emerald-50 border border-emerald-200 rounded-lg p-6 my-6">
          <h4 class="font-bold text-emerald-800 mb-4">üéØ The Selectivity Principle</h4>
          
          <table class="w-full text-sm mb-4">
            <thead>
              <tr class="border-b bg-emerald-100">
                <th class="text-left py-2 px-2 text-emerald-800">Receptor State</th>
                <th class="text-left py-2 px-2 text-emerald-800">Repels</th>
                <th class="text-left py-2 px-2 text-emerald-800">Accepts</th>
                <th class="text-left py-2 px-2 text-emerald-800">Functional Meaning</th>
              </tr>
            </thead>
            <tbody class="text-slate-700">
              <tr class="border-b">
                <td class="py-2 px-2 font-medium">Low GT1b</td>
                <td class="py-2 px-2 text-red-600">Weak charge (old)</td>
                <td class="py-2 px-2 text-green-600">Strong charge (fresh)</td>
                <td class="py-2 px-2 italic">Listen to nearby signals</td>
              </tr>
              <tr class="border-b bg-emerald-50">
                <td class="py-2 px-2 font-medium">High GT1b</td>
                <td class="py-2 px-2 text-red-600">Strong charge (fresh)</td>
                <td class="py-2 px-2 text-green-600">Weak charge (old)</td>
                <td class="py-2 px-2 italic">Listen to distant signals</td>
              </tr>
            </tbody>
          </table>

          <div class="bg-white rounded p-4 border border-emerald-200">
            <h5 class="font-bold text-emerald-700 mb-2">üß† Implications for Neural Computation</h5>
            <p class="text-slate-700 text-sm mb-2">
              This mechanism would allow neurons to:
            </p>
            <ul class="text-slate-600 text-sm space-y-1 ml-4 list-disc">
              <li><strong>Temporal integration:</strong> Accept signals over a specific time window</li>
              <li><strong>Spatial filtering:</strong> Respond only to nearby or distant sources</li>
              <li><strong>Dynamic tuning:</strong> Change selectivity by modifying membrane composition</li>
              <li><strong>Noise rejection:</strong> Ignore signals that are "too old" or "too fresh"</li>
            </ul>
          </div>
        </div>

        <!-- A-series vs B-series illustration -->
        <h3>The Great Divide: A-Series vs B-Series Function</h3>
        
        <figure class="my-8">
          <img 
            src="/images/a-series-vs-b-series-function.svg" 
            alt="A-series vs B-series gangliosides: showing internal (lysosomal) vs external (shedding) pathways"
            class="w-full rounded-lg border border-slate-200 shadow-lg bg-white"
          />
          <figcaption class="text-sm text-slate-600 mt-3 text-center">
            <strong>The Great Divide:</strong> A-series gangliosides are internalized and degraded (storage diseases 
            when this fails). B-series gangliosides are exported for intercellular communication (no storage diseases).
          </figcaption>
        </figure>

        <!-- PART 2: THE EVIDENCE -->
        <h2>The Evidence: Experiments That Prove the Model</h2>
        <p>
          The A-series vs B-series model isn't just theory. Unpublished neurotracing experiments 
          provide direct proof.
        </p>

        <h3>Evidence 1: The C-Fiber GM1 Switch</h3>
        <p>
          <strong>C-fibers</strong> (unmyelinated pain fibers) normally lack GM1. But after nerve injury:
        </p>

        <div class="bg-white rounded-lg border border-slate-200 p-4 my-4">
          <table class="w-full text-sm">
            <thead>
              <tr class="border-b bg-slate-50">
                <th class="text-left py-2 px-2">Condition</th>
                <th class="text-left py-2 px-2">GM1 Expression</th>
                <th class="text-left py-2 px-2">Interpretation</th>
              </tr>
            </thead>
            <tbody>
              <tr class="border-b">
                <td class="py-2 px-2">Healthy nerve</td>
                <td class="py-2 px-2 text-green-600 font-bold">Absent</td>
                <td class="py-2 px-2">B-series phenotype (communication mode)</td>
              </tr>
              <tr class="border-b">
                <td class="py-2 px-2">1 week post-injury</td>
                <td class="py-2 px-2 text-red-600 font-bold">Massively upregulated</td>
                <td class="py-2 px-2">Switched to A-series (storage mode)</td>
              </tr>
              <tr class="bg-amber-50">
                <td class="py-2 px-2">+ NGF (delayed)</td>
                <td class="py-2 px-2 text-green-600 font-bold">Normalized</td>
                <td class="py-2 px-2">Returned to B-series</td>
              </tr>
            </tbody>
          </table>
        </div>

        <div class="bg-amber-50 border border-amber-200 rounded-lg p-4 my-4">
          <h4 class="font-bold text-amber-800 mb-2">üèçÔ∏è The "Spain Protocol"</h4>
          <p class="text-amber-700 text-sm mb-2">
            Early NGF experiments showed no effect. A serendipitous delay (a motorcycle trip to Spain) 
            extended treatment duration by months ‚Äî and revealed that NGF <em>does</em> work, but 
            requires sustained signaling to reverse the injury phenotype.
          </p>
          <p class="text-amber-800 text-sm font-semibold mb-0">
            Published: <a href="https://journals.lww.com/neuroreport/abstract/2001/07030/delayed_administration_of_ngf_reverses_nerve.26.aspx" 
               class="text-blue-600 hover:underline" target="_blank">NeuroReport 2001</a>
          </p>
        </div>

        <h3>Evidence 2: Neuraminidase Unmasking</h3>
        <p>
          Chemical proof that C-fibers have complex gangliosides that "mask" GM1:
        </p>

        <div class="bg-purple-50 border border-purple-200 rounded-lg p-4 my-4">
          <p class="text-purple-700 text-sm mb-3">
            Cholera toxin B (CTB) binds GM1. When injected into nerves:
          </p>
          <ul class="text-purple-700 text-sm space-y-2 mb-3">
            <li><strong>CTB alone:</strong> No C-fiber labeling ‚Üí C-fibers lack surface GM1</li>
            <li><strong>CTB + neuraminidase:</strong> <span class="text-green-600 font-bold">Intense labeling!</span> ‚Üí Complex gangliosides converted to GM1</li>
          </ul>
          <div class="bg-purple-100 rounded p-3 font-mono text-sm text-center mb-3">
            GT1b/GD1b ‚Üí <span class="text-purple-500">(neuraminidase)</span> ‚Üí <strong class="text-blue-600">GM1</strong>
          </div>
          <p class="text-emerald-700 text-sm font-semibold mb-0 bg-emerald-50 rounded p-2">
            üéØ <strong>Critical finding:</strong> The labeling was most intense in <strong>lamina I</strong> ‚Äî 
            exactly where orexin neurons project their afferents.
          </p>
        </div>

        <div class="key-concept">
          <div class="key-concept-title">üß¨ The Complete Evidence Chain</div>
          <ol class="mt-2 mb-0 space-y-1">
            <li><strong>Normal state:</strong> C-fibers have B-series (GT1b, GD1b) ‚Äî GM1 is hidden</li>
            <li><strong>Chemical proof:</strong> Neuraminidase strips the complex coat ‚Üí GM1 exposed</li>
            <li><strong>Biological proof:</strong> Nerve injury activates endogenous sialidases ‚Üí same conversion</li>
            <li><strong>Reversal proof:</strong> NGF restores B-series ‚Üí GM1 disappears</li>
          </ol>
        </div>

        <!-- PART 3: IMPLICATIONS -->
        <h2>Implications for the Narcolepsy Hypothesis</h2>
        
        <p>
          Now we can connect all the pieces:
        </p>

        <div class="grid md:grid-cols-2 gap-4 my-6">
          <div class="bg-blue-50 border border-blue-200 rounded-lg p-4">
            <h4 class="font-bold text-blue-800 mb-2">‚úì What We Know</h4>
            <ul class="text-blue-700 text-sm space-y-1">
              <li>H1N1 virus binds GT1b (like tetanus toxin)</li>
              <li>GT1b-bound substances are released extraneuronally</li>
              <li>This release happens in lamina I</li>
              <li>Orexin neurons project to lamina I</li>
              <li>B3GALT4 (GT1b synthesis) is linked to HLA-DQB1*06:02</li>
            </ul>
          </div>
          <div class="bg-amber-50 border border-amber-200 rounded-lg p-4">
            <h4 class="font-bold text-amber-800 mb-2">üí° What We Propose</h4>
            <ul class="text-amber-700 text-sm space-y-1">
              <li>GT1b serves as a "neurotrophin highway"</li>
              <li>Vaccine antigens hijack this transport system</li>
              <li>The "HLA association" may be a B3GALT4 association</li>
              <li>Higher GT1b = more efficient vaccine transport to CNS</li>
            </ul>
          </div>
        </div>

        <div class="bg-gradient-to-r from-amber-100 to-orange-100 border border-amber-300 rounded-lg p-6 my-6">
          <h4 class="font-bold text-amber-900 mb-3">üîë Summary: The B-Series Advantage (and Vulnerability)</h4>
          <p class="text-amber-800 text-sm mb-3">
            The A-series vs B-series distinction explains everything:
          </p>
          <ol class="text-amber-800 text-sm space-y-2 mb-0">
            <li><strong>Why GT1b-bound antigens are released</strong> (like tetanus, unlike cholera)</li>
            <li><strong>Why there are no GT1b storage diseases</strong> (the shedding bypass)</li>
            <li><strong>Why vaccine antigens reach lamina I</strong> (the neurotrophin network)</li>
            <li><strong>Why some people are vulnerable</strong> (B3GALT4 variants ‚Üí more GT1b)</li>
          </ol>
        </div>
      </div>
    </div>
  </section>

  <!-- Synthesis: Connecting to Narcolepsy -->
  <section class="py-12 bg-gradient-to-b from-slate-800 to-slate-900 text-white">
    <div class="max-w-4xl mx-auto px-4 sm:px-6 lg:px-8">
      <h2 class="text-3xl font-bold mb-6 text-center">Putting It All Together: From GT1b to Narcolepsy</h2>
      <p class="text-slate-300 text-center mb-8 max-w-2xl mx-auto">
        The A-series vs B-series distinction provides the mechanistic foundation for understanding 
        how a vaccine injection in the arm can lead to destruction of orexin neurons in the hypothalamus.
      </p>

      <div class="bg-slate-700/50 rounded-xl p-6 mb-8">
        <h3 class="text-xl font-bold text-emerald-400 mb-4">üß¨ The Complete Mechanism in Five Steps</h3>
        
        <div class="space-y-4">
          <!-- Step 1 -->
          <div class="flex gap-4">
            <div class="flex-shrink-0 w-10 h-10 bg-emerald-500 rounded-full flex items-center justify-center font-bold text-white">1</div>
            <div>
              <h4 class="font-bold text-white">Intraneuronal Injection</h4>
              <p class="text-slate-300 text-sm">
                The vaccine needle penetrates the axillary nerve. Vaccine antigens (H1N1 components) 
                are deposited directly into nerve fascicles.
              </p>
            </div>
          </div>

          <!-- Step 2 -->
          <div class="flex gap-4">
            <div class="flex-shrink-0 w-10 h-10 bg-emerald-500 rounded-full flex items-center justify-center font-bold text-white">2</div>
            <div>
              <h4 class="font-bold text-white">GT1b Binding & B-Series Transport</h4>
              <p class="text-slate-300 text-sm">
                H1N1 antigens bind <strong class="text-emerald-400">GT1b ganglioside</strong> ‚Äî a B-series 
                ganglioside that serves as the transport receptor. This is the same receptor used by 
                tetanus toxin (not cholera toxin, which uses GM1/A-series).
              </p>
              <p class="text-amber-300 text-xs mt-1">
                <strong>Why GT1b matters:</strong> B-series gangliosides are "designed" for extracellular 
                communication, not intracellular storage. <em>We propose</em> that anything bound to GT1b 
                may follow a "neurotrophin highway" ‚Äî the same routes used by BDNF and GDNF.
              </p>
            </div>
          </div>

          <!-- Step 3 -->
          <div class="flex gap-4">
            <div class="flex-shrink-0 w-10 h-10 bg-emerald-500 rounded-full flex items-center justify-center font-bold text-white">3</div>
            <div>
              <h4 class="font-bold text-white">Retrograde Transport to Lamina I</h4>
              <p class="text-slate-300 text-sm">
                The GT1b-bound antigens travel retrogradely along the axon ‚Äî from the injection site 
                in the arm to the spinal cord (<strong class="text-emerald-400">lamina I</strong>). 
                This is the same pathway that neurons use to receive survival signals from target tissues.
              </p>
            </div>
          </div>

          <!-- Step 4 -->
          <div class="flex gap-4">
            <div class="flex-shrink-0 w-10 h-10 bg-red-500 rounded-full flex items-center justify-center font-bold text-white">4</div>
            <div>
              <h4 class="font-bold text-white">Extraneuronal Release (The Critical Difference)</h4>
              <p class="text-slate-300 text-sm">
                <strong class="text-red-400">This is where A-series and B-series diverge:</strong>
              </p>
              <ul class="text-slate-300 text-sm mt-2 space-y-1 ml-4">
                <li>‚Ä¢ <strong>A-series (GM1/Cholera toxin):</strong> Stays intracellular ‚Üí targets Golgi ‚Üí no immune exposure</li>
                <li>‚Ä¢ <strong>B-series (GT1b/Tetanus toxin):</strong> Released via EV shedding ‚Üí enters extracellular space ‚Üí exposes antigen to immune system</li>
              </ul>
              <p class="text-amber-300 text-xs mt-2">
                <strong>The neuraminidase experiments prove this:</strong> C-fibers have B-series gangliosides 
                (not GM1) ‚Äî when neuraminidase strips the sialic acids, GM1 appears. Critically, the labeling 
                was <strong>most intense in lamina I</strong> ‚Äî exactly where C-fibers terminate and where 
                orexin neurons project. B-series is the "communication mode"; A-series is the "storage mode".
              </p>
            </div>
          </div>

          <!-- Step 5 -->
          <div class="flex gap-4">
            <div class="flex-shrink-0 w-10 h-10 bg-amber-500 rounded-full flex items-center justify-center font-bold text-white">5</div>
            <div>
              <h4 class="font-bold text-white">Molecular Mimicry ‚Üí Orexin Cell Destruction</h4>
              <p class="text-slate-300 text-sm">
                In lamina I, the released antigens encounter <strong class="text-amber-400">orexin-containing 
                afferents</strong> from the hypothalamus (van den Pol, 1999). H1N1 nucleoprotein shares 
                structural homology with orexin receptor 2 (HcrtR2). Antibodies targeting the viral epitope 
                cross-react with orexin neurons ‚Üí selective destruction ‚Üí <strong class="text-red-400">narcolepsy</strong>.
              </p>
            </div>
          </div>
        </div>
      </div>

      <!-- Why the GM1/Neuraminidase Evidence Matters -->
      <div class="bg-purple-900/50 border border-purple-500/30 rounded-xl p-6 mb-8">
        <h3 class="text-xl font-bold text-purple-300 mb-4">üß™ Why the Neuraminidase Evidence Matters</h3>
        <p class="text-slate-300 text-sm mb-4">
          The unpublished neuraminidase experiments are not just technical details ‚Äî they are 
          <strong>mechanistic proof</strong> of why B-series transport is different:
        </p>
        <div class="grid md:grid-cols-2 gap-4">
          <div class="bg-slate-800 rounded-lg p-4">
            <h4 class="font-bold text-purple-300 mb-2">What We Observed</h4>
            <ul class="text-slate-300 text-xs space-y-1">
              <li>‚Ä¢ C-fibers normally <strong>don't bind CTB</strong> (GM1 marker)</li>
              <li>‚Ä¢ After neuraminidase: <strong>intense CTB binding</strong></li>
              <li>‚Ä¢ After nerve injury: <strong>same effect</strong> (endogenous sialidases)</li>
              <li>‚Ä¢ NGF treatment: <strong>reverses the switch</strong></li>
            </ul>
          </div>
          <div class="bg-slate-800 rounded-lg p-4">
            <h4 class="font-bold text-purple-300 mb-2">What This Proves</h4>
            <ul class="text-slate-300 text-xs space-y-1">
              <li>‚Ä¢ Healthy C-fibers have <strong>B-series gangliosides</strong></li>
              <li>‚Ä¢ GM1 (A-series) is "hidden" under the complex coat</li>
              <li>‚Ä¢ The switch is <strong>dynamically regulated</strong> by neurotrophins</li>
              <li>‚Ä¢ B-series = communication; A-series = storage</li>
            </ul>
          </div>
        </div>
        <p class="text-purple-200 text-sm mt-4 font-semibold">
          ‚Üí The vaccine antigen binds to B-series (GT1b), travels the communication highway, 
          and is released extraneuronally. If it had bound to A-series (GM1), it would stay 
          trapped inside the cell ‚Äî like cholera toxin.
        </p>
      </div>

      <!-- The Genetic Link -->
      <div class="bg-emerald-900/50 border border-emerald-500/30 rounded-xl p-6 mb-8">
        <h3 class="text-xl font-bold text-emerald-300 mb-4">üß¨ The Hidden Genetic Vulnerability</h3>
        <p class="text-slate-300 text-sm mb-4">
          Nearly 100% of Pandemrix-narcolepsy patients carry <strong>HLA-DQB1*06:02</strong>. 
          But what if the real culprit is a nearby gene?
        </p>
        <div class="bg-slate-800 rounded-lg p-4">
          <h4 class="font-bold text-emerald-300 mb-2">B3GALT4 ‚Äî The Overlooked Gene</h4>
          <p class="text-slate-300 text-xs mb-2">
            <strong>B3GALT4</strong> (Beta-1,3-galactosyltransferase 4) is located at <strong>6p21.32</strong> ‚Äî 
            directly within the HLA region, in linkage disequilibrium with DQB1*06:02.
          </p>
          <ul class="text-slate-300 text-xs space-y-1 ml-4">
            <li>‚Ä¢ B3GALT4 catalyzes <strong>GD2 ‚Üí GD1b</strong> (a critical step in GT1b biosynthesis)</li>
            <li>‚Ä¢ Variants that increase B3GALT4 activity ‚Üí <strong>more GT1b</strong></li>
            <li>‚Ä¢ More GT1b ‚Üí <strong>more efficient transport</strong> of vaccine antigens to CNS</li>
            <li>‚Ä¢ No storage disease phenotype (B-series is shed, not stored)</li>
          </ul>
          <p class="text-emerald-300 text-sm mt-3 font-semibold">
            ‚Üí The "HLA association" may actually be a <strong>B3GALT4 association</strong> ‚Äî 
            individuals with high GT1b production are more vulnerable to the Axonal Highway mechanism.
          </p>
        </div>
      </div>

      <!-- Final Summary Box -->
      <div class="bg-gradient-to-r from-amber-600 to-orange-600 rounded-xl p-6 text-center">
        <h3 class="text-2xl font-bold text-white mb-4">The Axonal Highway Hypothesis</h3>
        <p class="text-amber-100 mb-4">
          The H1N1 vaccine's affinity for <strong>GT1b ganglioside</strong> is not a coincidence ‚Äî 
          it's the key that unlocks access to the brain's internal communication network.
        </p>
        <div class="bg-white/20 rounded-lg p-4 text-left">
          <p class="text-white text-sm">
            <strong>Cholera toxin (GM1/A-series):</strong> Enters neuron ‚Üí stays inside ‚Üí no spread<br>
            <strong>Tetanus toxin (GT1b/B-series):</strong> Enters neuron ‚Üí released ‚Üí spreads trans-synaptically<br>
            <strong>H1N1 vaccine (GT1b/B-series):</strong> Enters neuron ‚Üí released in lamina I ‚Üí triggers autoimmunity ‚Üí <strong class="text-yellow-300">narcolepsy</strong>
          </p>
        </div>
        <div class="mt-4">
          <a href="/hypothesis/" class="inline-block bg-white text-amber-700 font-bold px-6 py-3 rounded-lg hover:bg-amber-100 transition-colors">
            Read the Full Hypothesis ‚Üí
          </a>
        </div>
      </div>
    </div>
  </section>

  <!-- References -->
  <section class="py-12 bg-slate-50">
    <div class="max-w-4xl mx-auto px-4 sm:px-6 lg:px-8">
      <h2 class="text-2xl font-bold text-slate-900 mb-6">References</h2>
      <ol class="reference-list text-slate-700">
        <li data-ref="[1]">
          Sasaki N, Toyoda M. (2019). Vascular Diseases and Gangliosides. 
          <em>Int J Mol Sci</em>. 20(24):6362. 
          <a href="https://doi.org/10.3390/ijms20246362" class="text-blue-600 hover:underline" target="_blank">doi:10.3390/ijms20246362</a>
        </li>
        <li data-ref="[2]">
          Noioso CM, et al. (2023). Miller Fisher syndrome: an updated narrative review. 
          <em>Front Neurol</em>. 14:1250774. 
          <a href="https://doi.org/10.3389/fneur.2023.1250774" class="text-blue-600 hover:underline" target="_blank">doi:10.3389/fneur.2023.1250774</a>
        </li>
        <li data-ref="[3]">
          Willison HJ, O'Hanlon GM. (1999). The immunopathogenesis of Miller Fisher syndrome. 
          <em>J Neuroimmunol</em>. 100(1-2):3-12. 
          <a href="https://doi.org/10.1016/S0165-5728(99)00213-1" class="text-blue-600 hover:underline" target="_blank">doi:10.1016/S0165-5728(99)00213-1</a>
        </li>
        <li data-ref="[4]">
          Wakerley BR, et al. (2014). Guillain-Barr√© and Miller Fisher syndromes‚Äînew diagnostic classification. 
          <em>Nat Rev Neurol</em>. 10(9):537-544. 
          <a href="https://doi.org/10.1038/nrneurol.2014.138" class="text-blue-600 hover:underline" target="_blank">doi:10.1038/nrneurol.2014.138</a>
        </li>
        <li data-ref="[5]">
          Trajkovic K, et al. (2008). Ceramide triggers budding of exosome vesicles into multivesicular endosomes. 
          <em>Science</em>. 319(5867):1244-1247. 
          <a href="https://doi.org/10.1126/science.1153124" class="text-blue-600 hover:underline" target="_blank">doi:10.1126/science.1153124</a>
        </li>
        <li data-ref="[6]">
          Svennerholm L. (1963). Chromatographic separation of human brain gangliosides. 
          <em>J Neurochem</em>. 10:613-623.
        </li>
        <li data-ref="[7]">
          Fotinou C, et al. (2001). The crystal structure of tetanus toxin Hc fragment 
          complexed with a synthetic GT1b analogue. <em>J Biol Chem</em>. 276(34):32274-32281.
        </li>
        <li data-ref="[8]">
          Rivero-Siri C, et al. (2001). Delayed administration of NGF reverses nerve 
          injury-induced changes in C-fiber GM1 expression. <em>NeuroReport</em>. 12(9):2021-5.
          <a href="https://journals.lww.com/neuroreport/abstract/2001/07030/delayed_administration_of_ngf_reverses_nerve.26.aspx" 
             class="text-blue-600 hover:underline" target="_blank">Link</a>
        </li>
        <li data-ref="[9]">
          Sariola H, Saarma M. (2003). Novel functions and signalling pathways for GDNF.
          <em>J Cell Sci</em>. 116(Pt 19):3855-62.
          <a href="https://pubmed.ncbi.nlm.nih.gov/12671643/" class="text-blue-600 hover:underline" target="_blank">PMID: 12671643</a>
        </li>
        <li data-ref="[10]">
          Schnaar RL, Lopez PH. (2009). Myelin-associated glycoprotein and its axonal receptors.
          <em>J Neurosci Res</em>. 87(15):3267-76.
          <a href="https://pubmed.ncbi.nlm.nih.gov/18623174/" class="text-blue-600 hover:underline" target="_blank">PMID: 18623174</a>
        </li>
        <li data-ref="[11]">
          Yuyama K, Sun H, Mitsutake S, Igarashi Y. (2012). Sphingolipid-modulated exosome secretion 
          promotes clearance of amyloid-Œ≤ by microglia. <em>J Biol Chem</em>. 287(14):10977-10989.
          <a href="https://doi.org/10.1074/jbc.M111.324640" class="text-blue-600 hover:underline" target="_blank">doi:10.1074/jbc.M111.324640</a>
        </li>
        <li data-ref="[12]">
          Maccari F, Galeotti F, Capone S, et al. (2018). Gangliosides and biological membranes: 
          The different ways to be a lipid. <em>Adv Exp Med Biol</em>. 1109:23-54.
          <a href="https://doi.org/10.1007/978-3-030-03065-0_2" class="text-blue-600 hover:underline" target="_blank">doi:10.1007/978-3-030-03065-0_2</a>
        </li>
        <li data-ref="[13]">
          Poon WW, McGrady AJ, Bhullar RK, Bhullar AS, Bhullar SS, Bhullar RS. (2004). 
          Modulation of nerve growth factor transport by ganglioside GM1 in PC12 cells. 
          <em>Neurochem Res</em>. 29(11):2041-2047.
          <a href="https://doi.org/10.1007/s11064-004-6876-2" class="text-blue-600 hover:underline" target="_blank">doi:10.1007/s11064-004-6876-2</a>
        </li>
        <li data-ref="[14]">
          Iguchi Y, Natsume R, Kaneko R, et al. (2023). Exosome secretion from neurons and its 
          role in the modulation of synaptic activity. <em>Neurochem Int</em>. 169:105593.
          <a href="https://doi.org/10.1016/j.neuint.2023.105593" class="text-blue-600 hover:underline" target="_blank">doi:10.1016/j.neuint.2023.105593</a>
        </li>
      </ol>
    </div>
  </section>
</BaseLayout>
